HHS Secretary McClellan?
This article was originally published in The Gray Sheet
Executive Summary
Tommy Thompson will step down from the HHS secretary spot Feb. 4 or when a successor is named, he announces Dec. 3. CMS Administrator Mark McClellan, MD/PhD, and HHS Deputy Secretary Claude Allen, JD, are considered leading contenders to replace him. Thompson also mentioned CDC Director Julie Gerberding, MD/MPH; NIH Director Elias Zerhouni, MD; and National Institute of Allergy & Infectious Diseases DirectorAnthony Fauci, MD, as possible successors. The search has moved outside the department, with some state governors reportedly interviewed; former Speaker of the House Newt Gingrich also has voiced interest. Although not discounting a future role in public service, Thompson said that after 38 years he is ready to enter the private sector. He lauded HHS' work on the Medicare Modernization Act, while conceding he "would like to have had the opportunity to negotiate" its details...
You may also be interested in...
HHS Secretary-Designate Leavitt’s Record Suggests Tech-Friendly Outlook
Former Utah Governor and current Environmental Protection Agency Administrator Michael Leavitt brings to the HHS secretary post a pro-business, pro-innovation record that could bode well for med tech firms
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.